Litcius/Paper detail

The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management

Ian Giles, Iona Thorne, Nanna Surlemont Schmidt, Claire Reid, Amy Crossley, Monica Panca, Nick Freemantle, Clare Tower, Shouvik Dass, Shefali Sharma, David Williams, Sean O'Neill, Radboud J E M Dolhain, Nataša Toplak, Kenneth Hodson, Catherine Nelson-Piercy, Megan E B Clowse

2024The Lancet Rheumatology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDiscontinuationPregnancyIntensive care medicineAdverse effectDiseaseArthritisInflammatory arthritisUnintended pregnancyInternal medicinePhysical therapyFamily planningPopulationResearch methodologyEnvironmental healthBiologyGeneticsPregnancy and Medication ImpactReproductive System and PregnancyEosinophilic Esophagitis
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management | Litcius